HK1018400A1 - Sustained-release microgranules containing diltiazem as active principle - Google Patents

Sustained-release microgranules containing diltiazem as active principle

Info

Publication number
HK1018400A1
HK1018400A1 HK99103442A HK99103442A HK1018400A1 HK 1018400 A1 HK1018400 A1 HK 1018400A1 HK 99103442 A HK99103442 A HK 99103442A HK 99103442 A HK99103442 A HK 99103442A HK 1018400 A1 HK1018400 A1 HK 1018400A1
Authority
HK
Hong Kong
Prior art keywords
sustained
active principle
microgranules containing
release microgranules
containing diltiazem
Prior art date
Application number
HK99103442A
Other languages
English (en)
Inventor
Patrice Debregeas
Gerard Leduc
Pascal Oury
Pascal Suplie
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9485856&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1018400(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Publication of HK1018400A1 publication Critical patent/HK1018400A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK99103442A 1995-12-22 1999-08-10 Sustained-release microgranules containing diltiazem as active principle HK1018400A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9515361A FR2742660B1 (fr) 1995-12-22 1995-12-22 Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
PCT/FR1996/002040 WO1997023219A1 (fr) 1995-12-22 1996-12-23 Microgranules a liberation prolongee contenant du diltiazem comme principe actif

Publications (1)

Publication Number Publication Date
HK1018400A1 true HK1018400A1 (en) 1999-12-24

Family

ID=9485856

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99103442A HK1018400A1 (en) 1995-12-22 1999-08-10 Sustained-release microgranules containing diltiazem as active principle

Country Status (27)

Country Link
US (3) US6228395B1 (ko)
EP (1) EP0868184B1 (ko)
JP (1) JP2000506500A (ko)
KR (1) KR100354054B1 (ko)
CN (1) CN1145488C (ko)
AR (1) AR004410A1 (ko)
AT (1) ATE238798T1 (ko)
AU (1) AU721949B2 (ko)
BG (1) BG63770B1 (ko)
BR (1) BR9612225A (ko)
CA (1) CA2242224C (ko)
DE (1) DE69627880T2 (ko)
DK (1) DK0868184T3 (ko)
EA (1) EA001721B1 (ko)
EE (1) EE04045B1 (ko)
ES (1) ES2198505T3 (ko)
FR (1) FR2742660B1 (ko)
GE (1) GEP20022629B (ko)
HK (1) HK1018400A1 (ko)
HU (1) HU224214B1 (ko)
IL (1) IL125047A (ko)
NO (1) NO324680B1 (ko)
NZ (1) NZ324739A (ko)
PL (1) PL186621B1 (ko)
PT (1) PT868184E (ko)
WO (1) WO1997023219A1 (ko)
ZA (1) ZA9610776B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
US6162463A (en) * 1997-05-01 2000-12-19 Dov Pharmaceutical Inc Extended release formulation of diltiazem hydrochloride
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
US7179483B2 (en) 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
FR2831546B1 (fr) * 2001-10-31 2007-03-23 Atofina Materiau polymere thermoplastique pour supports d'enregistrement d'informations audio et/ou optiques
EP1689373B1 (en) * 2003-10-10 2019-04-03 Ethypharm Sustained-release microgranules containing ginkgo biloba extract and the process for manufacturing these
JPWO2005065715A1 (ja) * 2003-12-25 2007-07-26 武田薬品工業株式会社 造粒性改善方法
JP2005306778A (ja) * 2004-04-21 2005-11-04 Basf Ag 徐放性製剤及びその製造方法
WO2006013431A1 (en) * 2004-07-29 2006-02-09 Pfizer Limited Stable controlled-release pharmaceutical formulation of eletriptan
US8778395B2 (en) * 2005-08-11 2014-07-15 Andrx Labs, Llc Diltiazem controlled release formulation and method of manufacture
ES2385612T3 (es) * 2006-06-19 2012-07-27 Alpharma Pharmaceuticals, Llc Composiciones farmacéuticas
ITFI20110172A1 (it) 2011-08-08 2013-02-09 Valpharma Sa Formulazione multiparticolata a rilascio modificato di diltiazem hcl.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale
DK173505B1 (da) * 1987-02-20 2001-01-15 Pharmatec Internat S R L Fremgangsmåde til fremstilling af en diltiazempellet med langsom afgivelse og anvendelse af således fremstillede pelleter t
JPH07552B2 (ja) * 1987-11-06 1995-01-11 田辺製薬株式会社 持効性製剤
FR2623714B1 (fr) * 1987-11-26 1990-04-20 Ethypharm Sa Forme a liberation prolongee du diltiazem, et son medicament ainsi obtenu
FR2624732B1 (fr) * 1987-12-21 1991-02-15 Synthelabo Formulation pharmaceutique a liberation prolongee
FR2630647B1 (fr) * 1988-04-27 1991-08-16 Sanofi Sa Microbilles de diltiazem, leur procede de fabrication et compositions pharmaceutiques a liberation prolongee les contenant
US5288505A (en) 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
US5229135A (en) * 1991-11-22 1993-07-20 Prographarm Laboratories Sustained release diltiazem formulation
US5376384A (en) 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
US5834024A (en) * 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif

Also Published As

Publication number Publication date
ES2198505T3 (es) 2004-02-01
PT868184E (pt) 2003-09-30
BR9612225A (pt) 1999-07-13
DE69627880D1 (de) 2003-06-05
JP2000506500A (ja) 2000-05-30
HUP9904129A2 (hu) 2000-04-28
CN1207681A (zh) 1999-02-10
ATE238798T1 (de) 2003-05-15
HUP9904129A3 (en) 2000-11-28
DK0868184T3 (da) 2003-08-25
KR100354054B1 (ko) 2003-02-14
NO324680B1 (no) 2007-12-03
HU224214B1 (hu) 2005-06-28
NZ324739A (en) 2000-01-28
EA199800593A1 (ru) 1998-12-24
EE9800197A (et) 1998-12-15
FR2742660A1 (fr) 1997-06-27
GEP20022629B (en) 2002-02-25
CA2242224A1 (fr) 1997-07-03
IL125047A0 (en) 1999-01-26
DE69627880T2 (de) 2004-03-11
EE04045B1 (et) 2003-06-16
EA001721B1 (ru) 2001-08-27
PL327567A1 (en) 1998-12-21
US20020182253A1 (en) 2002-12-05
AR004410A1 (es) 1998-11-04
US6660296B2 (en) 2003-12-09
AU721949B2 (en) 2000-07-20
US6228395B1 (en) 2001-05-08
ZA9610776B (en) 1997-06-30
CA2242224C (fr) 2004-01-13
NO982738L (no) 1998-08-21
CN1145488C (zh) 2004-04-14
KR19990076717A (ko) 1999-10-15
WO1997023219A1 (fr) 1997-07-03
EP0868184B1 (fr) 2003-05-02
EP0868184A1 (fr) 1998-10-07
IL125047A (en) 2003-05-29
BG102555A (en) 1999-02-26
AU1198397A (en) 1997-07-17
PL186621B1 (pl) 2004-02-27
NO982738D0 (no) 1998-06-12
BG63770B1 (bg) 2002-12-29
FR2742660B1 (fr) 1998-04-03
US6383516B1 (en) 2002-05-07

Similar Documents

Publication Publication Date Title
EP1018864A4 (en) CAGE FOR TRANSPORTING ANIMALS
ZA9610776B (en) Sustained-release microgranules containing diltiazem as active principle
ZA963849B (en) Active compound combinations
PL324408A1 (en) Pesticidal compounds
SG87744A1 (en) Hydrophobic bioremediants
EP0859007A4 (en) CYCLIC HEXAPEPTIDE
GB9616628D0 (en) Animal carrier
GB9515071D0 (en) Microencapsulation
AU125290S (en) Sinker
GB9500390D0 (en) Pesticidal compounds
GB9513550D0 (en) Pesticidal compounds
GB9513573D0 (en) Pesticidal compounds
GB9513584D0 (en) Pesticidal compounds
GB9513594D0 (en) Pesticidal compounds
GB9513595D0 (en) Pesticidal compounds
GB9523165D0 (en) Pesticidal compounds
GB9504696D0 (en) Improved carrier
TW344952U (en) Improved structure for connecting-ring
GB9808367D0 (en) Alkylphosphines as pesticidal agents
GB9505677D0 (en) Pharmaceutically active compounds
GB9518039D0 (en) Pharmaceutically active compounds
GB9506274D0 (en) Pharmaceutically active compounds
GB9502229D0 (en) Pharmaceutically active compounds
GB9502429D0 (en) Pharmaceutically active compounds
GB9502541D0 (en) Pharmaceutically active compounds

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20161222